Best Primary Sclerosing Cholangitis Treatment Doctors in India
Dr. Murugan N
Whatsapp Us
Dr. Sanjiv Saigal
Dr. Charles Panackel
Dr. Mallikarjun Sakpal
Dr. Narendra Singh Choudhary
Dr. Geeta Malkan Billa
What Patients with Primary Sclerosing Cholangitis Worry About Most
Primary sclerosing cholangitis is a chronic disease that scars the inside and outside bile ducts, causing strictures and eventually cirrhosis. Patients worry about cholangitis attacks, about cholangiocarcinoma, about the link with inflammatory bowel disease, and about needing a liver transplant. Many are young men already on ursodeoxycholic acid with raised alkaline phosphatase. The honest position is that no medical therapy reliably slows primary sclerosing cholangitis, but careful surveillance and endoscopic management of dominant strictures preserve liver function for years. Liver transplantation is the definitive treatment and has excellent outcomes.
How Primary Sclerosing Cholangitis Is Diagnosed
Diagnosis is made by magnetic resonance cholangiopancreatography showing the characteristic beaded appearance of intra- and extra-hepatic bile ducts. Liver function tests show a cholestatic pattern. Anti-neutrophil cytoplasmic antibodies are often positive but non-specific. Liver biopsy is used selectively to grade fibrosis or diagnose small duct disease where cholangiogram is normal. Colonoscopy is mandatory at diagnosis since around seventy percent of patients have inflammatory bowel disease, often mild and quiescent at presentation. Carbohydrate antigen 19-9 and imaging surveillance look for cholangiocarcinoma.
Treatment Options for Primary Sclerosing Cholangitis in India
No medical therapy reliably slows progression. Ursodeoxycholic acid at moderate doses (thirteen to fifteen milligrams per kilogram per day) improves biochemistry without clear survival benefit and is used in selected patients. High doses (above twenty-eight milligrams per kilogram) are harmful and avoided. Endoscopic retrograde cholangiopancreatography with balloon dilation, with or without short-term stenting, treats dominant strictures that cause jaundice, itching, or cholangitis. Antibiotics manage acute cholangitis. Inflammatory bowel disease is treated by a gastroenterologist with standard therapy. Surveillance colonoscopy is offered annually because colon cancer risk is high. Imaging and tumour markers screen for cholangiocarcinoma. Liver transplantation is the only treatment that improves long-term survival in advanced disease. Institute of Liver and Biliary Sciences, Fortis Memorial Research Institute, Medanta, Apollo Hospitals, Asian Institute of Gastroenterology, and All India Institute of Medical Sciences run dedicated primary sclerosing cholangitis programmes.
Recovery, Success Rates, and Follow-Up
Median time from diagnosis to liver transplantation or death is around twenty years in adults. Endoscopic balloon dilation of dominant strictures relieves jaundice and cholangitis in most cases and may be needed periodically. Liver transplantation has five-year survival above seventy-five percent, with recurrence of primary sclerosing cholangitis in the graft in around twenty percent at ten years. Cholangiocarcinoma develops in around ten to fifteen percent over a lifetime and is the major cause of death from the disease. Surveillance reduces both cholangiocarcinoma and colon cancer mortality.
How to Choose the Right Hepatobiliary Unit for Primary Sclerosing Cholangitis
Ask the unit about volumes of endoscopic retrograde cholangiopancreatography for primary sclerosing cholangitis, cholangioscopy for indeterminate strictures, multidisciplinary hepatobiliary meetings, and the link with a liver transplant programme. Ask about the personalised plan for cholangiocarcinoma surveillance and inflammatory bowel disease care under one roof. Ask about colonoscopy with chromoendoscopy for dysplasia surveillance.
International Patient Support
International patients receive a single coordinator who arranges hepatology and gastroenterology consults, magnetic resonance cholangiopancreatography, endoscopic retrograde cholangiopancreatography, colonoscopy, and transplant evaluation. The Cancer Rounds team supports medical visa invitation letters, accommodation, airport transfers, and multilingual support in eleven plus languages. Patients arrive from Nigeria, Bangladesh, Kenya, Ethiopia, Iraq, Oman, and the United Arab Emirates for primary sclerosing cholangitis care. A written long-term plan and cost estimate are shared before travel.
Frequently Asked Questions
Why does primary sclerosing cholangitis link with inflammatory bowel disease?
Around seventy percent of patients with primary sclerosing cholangitis have inflammatory bowel disease, usually ulcerative colitis. The shared autoimmune mechanism is not fully understood. Annual surveillance colonoscopy is essential because colon cancer risk is significantly increased.
Will I get cholangiocarcinoma?
Cholangiocarcinoma develops in around ten to fifteen percent of patients over a lifetime, most often in the first two years after diagnosis. Annual magnetic resonance cholangiopancreatography and carbohydrate antigen 19-9 are part of surveillance. Suspicious strictures are evaluated with cholangioscopy.
Does ursodeoxycholic acid help?
Ursodeoxycholic acid improves liver biochemistry in most patients without clear survival benefit. Moderate doses are used in selected patients. High doses above twenty-eight milligrams per kilogram per day are harmful and avoided.
What is a dominant stricture?
A dominant stricture is a narrowing of one of the larger bile ducts that causes jaundice, itching, or cholangitis. It is treated by endoscopic balloon dilation with or without short-term stenting. Biopsy and cytology rule out cholangiocarcinoma.
When is liver transplantation needed?
Liver transplantation is offered for decompensated cirrhosis, intractable itching, recurrent cholangitis not controlled by antibiotics, and selected early hilar cholangiocarcinoma under the Mayo protocol. Outcomes are excellent in dedicated transplant centres.
Is colon cancer screening different for primary sclerosing cholangitis?
Yes. Patients with primary sclerosing cholangitis and inflammatory bowel disease need annual colonoscopy starting from primary sclerosing cholangitis diagnosis, with chromoendoscopy or high-definition imaging to detect early dysplasia. This is the most intensive bowel cancer surveillance offered.
